Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16869742rdf:typepubmed:Citationlld:pubmed
pubmed-article:16869742lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:16869742lifeskim:mentionsumls-concept:C0000768lld:lifeskim
pubmed-article:16869742lifeskim:mentionsumls-concept:C0043292lld:lifeskim
pubmed-article:16869742lifeskim:mentionsumls-concept:C0376571lld:lifeskim
pubmed-article:16869742lifeskim:mentionsumls-concept:C0205422lld:lifeskim
pubmed-article:16869742lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:16869742lifeskim:mentionsumls-concept:C0205214lld:lifeskim
pubmed-article:16869742lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:16869742lifeskim:mentionsumls-concept:C0205254lld:lifeskim
pubmed-article:16869742pubmed:dateCreated2006-7-27lld:pubmed
pubmed-article:16869742pubmed:abstractTextAs a clinical entity, breast cancer appears to be a series of subforms, each with a relatively specific molecular phenotype. Among the characteristics that differentiate these subforms are sex hormone receptor expression, HER2 expression, p53 mutation, high-grade histopathology, and particular gene expression array patterns. Sporadic basal-like breast cancer is one such form. It is a relatively common, high-grade, hormone receptor and HER2-expression-negative, p53 mutation-bearing tumor and is particularly lethal. Although wild type for BRCA1, it is a sporadic phenocopy of most cases of BRCA1(/) breast cancer. Not only do the cells of the two tumors resemble one another with respect to the above-noted characteristics, they also share a defect in the maintenance of an intact, inactive X chromosome (Xi). Other high-grade and most low-grade tumors are rarely defective at Xi. This evidence suggests that an Xi defect contributes to the evolution of both sporadic and BRCA1(/) basal-like breast tumors.lld:pubmed
pubmed-article:16869742pubmed:languageenglld:pubmed
pubmed-article:16869742pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16869742pubmed:citationSubsetIMlld:pubmed
pubmed-article:16869742pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16869742pubmed:statusMEDLINElld:pubmed
pubmed-article:16869742pubmed:issn0091-7451lld:pubmed
pubmed-article:16869742pubmed:authorpubmed-author:LivingstonD...lld:pubmed
pubmed-article:16869742pubmed:authorpubmed-author:GanesanSSlld:pubmed
pubmed-article:16869742pubmed:authorpubmed-author:SilverDDlld:pubmed
pubmed-article:16869742pubmed:authorpubmed-author:FeunteunJJlld:pubmed
pubmed-article:16869742pubmed:authorpubmed-author:IglehartJ DJDlld:pubmed
pubmed-article:16869742pubmed:authorpubmed-author:WangZ CZClld:pubmed
pubmed-article:16869742pubmed:authorpubmed-author:RichardsonA...lld:pubmed
pubmed-article:16869742pubmed:authorpubmed-author:MironAAlld:pubmed
pubmed-article:16869742pubmed:issnTypePrintlld:pubmed
pubmed-article:16869742pubmed:volume70lld:pubmed
pubmed-article:16869742pubmed:ownerNLMlld:pubmed
pubmed-article:16869742pubmed:authorsCompleteYlld:pubmed
pubmed-article:16869742pubmed:pagination93-7lld:pubmed
pubmed-article:16869742pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16869742pubmed:meshHeadingpubmed-meshheading:16869742...lld:pubmed
pubmed-article:16869742pubmed:meshHeadingpubmed-meshheading:16869742...lld:pubmed
pubmed-article:16869742pubmed:meshHeadingpubmed-meshheading:16869742...lld:pubmed
pubmed-article:16869742pubmed:meshHeadingpubmed-meshheading:16869742...lld:pubmed
pubmed-article:16869742pubmed:meshHeadingpubmed-meshheading:16869742...lld:pubmed
pubmed-article:16869742pubmed:meshHeadingpubmed-meshheading:16869742...lld:pubmed
pubmed-article:16869742pubmed:meshHeadingpubmed-meshheading:16869742...lld:pubmed
pubmed-article:16869742pubmed:meshHeadingpubmed-meshheading:16869742...lld:pubmed
pubmed-article:16869742pubmed:meshHeadingpubmed-meshheading:16869742...lld:pubmed
pubmed-article:16869742pubmed:meshHeadingpubmed-meshheading:16869742...lld:pubmed
pubmed-article:16869742pubmed:year2005lld:pubmed
pubmed-article:16869742pubmed:articleTitleAbnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer.lld:pubmed
pubmed-article:16869742pubmed:affiliationDana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA.lld:pubmed
pubmed-article:16869742pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16869742pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:16869742pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16869742lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16869742lld:pubmed